Current Issue


Mortality rates, deaths from vascular causes among U.S. adults with diabetes have decreased over time

Between 1988 to 1994 and 2010 to 2015, all-cause mortality rates among adults with diabetes dropped most in men and those ages 65 to 74 years, and there was no decline in death rates among those ages 20 to 44 years.

Study finds potential early indicators of myocardial dysfunction in asymptomatic elderly patients with type 2 diabetes

Researchers examined asymptomatic patients 65 years of age and older with type 2 diabetes and preserved left ventricular ejection fraction to look for impaired global longitudinal strain, diastolic dysfunction, or left atrial enlargement.

ADA suggests ways to improve insulin affordability

The American Diabetes Association calls for increasing transparency across the entire supply chain, streamlining the approval process for biosimilars, lowering or removing patient cost-sharing, and increasing access to health care coverage for people with diabetes.

MKSAP quiz: Glycemic fluctuations in type 1 diabetes

This month's quiz asks readers to evaluate a 25-year-old woman with type 1 diabetes whose treatment regimen is insulin glargine once daily and insulin lispro three times daily.

Spotlight on self-management

One study found that personalized text messaging improved patients' self-management while another looked at the potential value of providing social comparisons to other patients' diabetes control.

In type 2 diabetes with CVD and kidney disease, empagliflozin reduced mortality and hospitalization

If the results are confirmed, sodium–glucose co-transporter-2 inhibitors will become a dominant strategy over standard glucose-lowering therapies for treating diabetic kidney disease, according to the ACP Journal Club commentary.

In high-risk T1DM, real-time continuous glucose monitoring vs self-monitoring reduced hypoglycemic events

The study provides compelling evidence for clinicians to recommend real-time continuous glucose monitoring to their patients at high risk for severe hypoglycemia, the ACP Journal Club commentary said.

Reconciling conflicting diabetes guidance

ACP Internist discusses disagreement among professional medical societies on appropriate glycemic control goals following ACP's recent guidance recommending a higher target HbA1c.